Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday . The company traded as high as GBX 7.50 ($0.09) and last traded at GBX 7.20 ($0.09), with a volume of 2510080 shares changing hands. The stock had previously closed at GBX 7 ($0.09).
Allergy Therapeutics Price Performance
The business’s 50 day simple moving average is GBX 5.83 and its 200-day simple moving average is GBX 5.15. The stock has a market capitalization of £348.21 million, a price-to-earnings ratio of -121.67, a price-to-earnings-growth ratio of -30.70 and a beta of 1.40. The company has a debt-to-equity ratio of 37.22, a quick ratio of 1.48 and a current ratio of 1.40.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Articles
- Five stocks we like better than Allergy Therapeutics
- Conference Calls and Individual Investors
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- How to Use the MarketBeat Stock Screener
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
